Cathy Zhou
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 41
- Chronic Lymphocytic Leukemia Research 41
-
- Lymphoma Diagnosis and Treatment 25
- Co-authors
- Danelle F. James (13 shared papers)William G. Wierda (26 shared papers)Jan A. Burger (10 shared papers)Steven Coutré (9 shared papers)Alessandra Tedeschi (27 shared papers)Carol Moreno (16 shared papers)Susan O’Brien (11 shared papers)Richard R. Furman (5 shared papers)
- Journals
- Blood (12 papers)Journal of Clinical Oncology (8 papers)Hematological Oncology (4 papers)HemaSphere (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Cathy Zhou
41 papers receiving 1.5k citations
Cathy Zhou's Hit Papers
Peers
Comparison fields: 5 of 40
- Genetics 1.4k
- Pathology and Forensic Medicine 961
- Hematology 387
- Immunology 412
- Gastroenterology 65
Countries citing papers authored by Cathy Zhou
This map shows the geographic impact of Cathy Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Zhou more than expected).
Fields of papers citing papers by Cathy Zhou
This network shows the impact of papers produced by Cathy Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Zhou. The network helps show where Cathy Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Cathy Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib Hit paper breakdown → | 2015 | 484 |
| 2 | Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2018 | 386 |
| 3 | Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia Hit paper breakdown → | 2022 | 163 |
| 4 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort Hit paper breakdown → | 2022 | 139 |
| 5 | 2017 | 48 | |
| 6 | 2012 | 38 | |
| 7 | 2018 | 32 | |
| 8 | 2019 | 31 | |
| 9 | 2020 | 31 | |
| 10 | 2023 | 24 | |
| 11 | 2018 | 21 | |
| 12 | 2021 | 16 | |
| 13 | 2018 | 16 | |
| 14 | 2023 | 10 | |
| 15 | 2025 | 10 | |
| 16 | 2014 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2024 | 8 | |
| 19 | 2014 | 7 | |
| 20 | 2018 | 7 |
About Cathy Zhou
Cathy Zhou is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Immunology and Public Health, Environmental and Occupational Health, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (41 papers), Lymphoma Diagnosis and Treatment (25 papers), Chronic Myeloid Leukemia Treatments (15 papers), Acute Lymphoblastic Leukemia research (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Advanced Breast Cancer Therapies (3 papers), Gastrointestinal Tumor Research and Treatment (1 paper) and Blood Coagulation and Thrombosis Mechanisms (1 paper). The work is most often cited by research in Genetics (1.4k citations), Pathology and Forensic Medicine (961 citations), Hematology (387 citations), Immunology (412 citations) and Gastroenterology (65 citations). Cathy Zhou has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Danelle F. James, William G. Wierda, Jan A. Burger, Steven Coutré, Alessandra Tedeschi, Carol Moreno, Susan O’Brien, Richard R. Furman, Jeffrey A. Jones and John C. Byrd. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, HemaSphere and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.